Dolby Laboratories, Inc. (DLB)
After hours:
| Previous close | 75.11 |
| Open | 75.07 |
| Bid | 66.00 x 1200 |
| Ask | 79.00 x 800 |
| Day's range | 73.88 - 76.26 |
| 52-week range | 69.18 - 104.25 |
| Volume | |
| Avg. volume | 531,344 |
| Market cap | 7.601B |
| Beta (5Y monthly) | 0.99 |
| PE ratio (TTM) | 36.20 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.00 (1.33%) |
| Ex-dividend date | 16 May 2022 |
| 1y target est | N/A |
- GlobeNewswire
Dolby Laboratories President and CEO Kevin Yeaman to Present at the J.P. Morgan Technology, Media, and Communications Conference
SAN FRANCISCO, May 17, 2022 (GLOBE NEWSWIRE) -- Dolby Laboratories, Inc. (NYSE:DLB) today announced that Kevin Yeaman, President and CEO, Dolby Laboratories, will present at the 50th Annual J.P. Morgan Technology, Media, and Communications Conference in Boston, Massachusetts, on Wednesday, May 25, 2022, at 1:50 p.m. ET (10:50 a.m. PT). A live webcast and replay of the presentation will be available at http://investor.dolby.com. About Dolby LaboratoriesDolby Laboratories (NYSE: DLB) is based in S
- GlobeNewswire
Dolby Laboratories Reports Second Quarter Fiscal 2022 Financial Results
SAN FRANCISCO, May 05, 2022 (GLOBE NEWSWIRE) -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the second quarter of fiscal 2022. For the second quarter, Dolby reported total revenue of $334.4 million, compared to $319.6 million for the second quarter of fiscal 2021. "We feel confident about our long term growth opportunities despite near term headwinds," said Kevin Yeaman, President and CEO, Dolby Laboratories. "Our partners continue to enable a growing
- GlobeNewswire
Dolby Laboratories Announces Dr. Shriram Revankar as SVP Advanced Technology Group
Seasoned Technologist and Industry Leader brings Decades of Leadership and Innovation to Dolby Dr. Shriram Revankar Dolby Laboratories Announces Dr. Shriram Revankar as SVP Advanced Technology Group SAN FRANCISCO, May 03, 2022 (GLOBE NEWSWIRE) -- Dolby Laboratories, Inc. (NYSE:DLB), a leader in immersive entertainment experiences, today announced the appointment of Dr. Shriram Revankar, a technologist and industry leader who has cultivated teams across multiple disciplines to deliver high impact
